Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03880227 · ClinicalTrials.gov registry record · NA
Improving Visual Attention in Schizophrenia
A NA study, sponsored by The University of Texas at Dallas.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT03880227 is a NA study that has completed, run by The University of Texas at Dallas. The registered enrollment target is 81 participants.
The verdict
NCT03880227, a NA study, has completed, sponsored by The University of Texas at Dallas.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
This study investigates whether visual attention can be improved in individuals with schizophrenia by stimulating the brain via transcranial Direct Current Stimulation (tDCS).
Interventions
- DEVICE Sham tDCS
- DEVICE Active anodal tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2019-03-25 |
| Est. Completion | 2020-03-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03880227
The ClinicalTrials.gov registry entry for NCT03880227 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas at Dallas, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham tDCS is the first listed.
NCT03880227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03880227 about?
NCT03880227 is a clinical study titled "Improving Visual Attention in Schizophrenia". This study investigates whether visual attention can be improved in individuals with schizophrenia by stimulating the brain via transcranial Direct Current Stimulation (tDCS).
What is the current status of trial NCT03880227?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2019-03-25. Estimated completion is 2020-03-04.
What interventions are being tested in trial NCT03880227?
The interventions under investigation include: Sham tDCS (DEVICE), Active anodal tDCS (DEVICE).
Who is sponsoring clinical trial NCT03880227?
This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.